The International Circumpolar Surveillance interlaboratory quality control program for Streptococcus pneumoniae, 1999 to 2008.
Identifieur interne : 001583 ( Main/Exploration ); précédent : 001582; suivant : 001584The International Circumpolar Surveillance interlaboratory quality control program for Streptococcus pneumoniae, 1999 to 2008.
Auteurs : A. Reasonover [États-Unis] ; T. Zulz ; M G Bruce ; D. Bruden ; L. Jetté ; M. Kaltoft ; L. Lambertsen ; A. Parkinson ; K. Rudolph ; M. LovgrenSource :
- Journal of clinical microbiology [ 1098-660X ] ; 2011.
Descripteurs français
English descriptors
- KwdEn :
- Alaska, Bacterial Typing Techniques (methods), Bacterial Typing Techniques (standards), Bacteriological Techniques (standards), Canada, Denmark, Humans, Iceland, International Cooperation, Microbial Sensitivity Tests (methods), Microbial Sensitivity Tests (standards), Pneumococcal Infections (diagnosis), Pneumococcal Infections (microbiology), Quality Control, Serotyping (methods), Serotyping (standards), Streptococcus pneumoniae (classification), Streptococcus pneumoniae (drug effects), Streptococcus pneumoniae (isolation & purification).
- MESH :
- geographic : Alaska, Canada, Denmark, Iceland.
- classification : Streptococcus pneumoniae.
- diagnosis : Pneumococcal Infections.
- drug effects : Streptococcus pneumoniae.
- isolation & purification : Streptococcus pneumoniae.
- methods : Bacterial Typing Techniques, Microbial Sensitivity Tests, Serotyping.
- microbiology : Pneumococcal Infections.
- standards : Bacterial Typing Techniques, Bacteriological Techniques, Microbial Sensitivity Tests, Serotyping.
- Humans, International Cooperation, Quality Control.
Abstract
The International Circumpolar Surveillance (ICS) Program was initiated in 1999 to conduct population-based surveillance for invasive pneumococcal disease in select regions of the Arctic. An interlaboratory quality control (QC) program for pneumococcal serotyping and antibiotic susceptibility testing was incorporated into ICS by reference laboratories in northern Canada (Laboratoire de Santé Publique du Québec [LSPQ] in Sainte-Anne de Bellevue, Québec; National Centre for Streptococcus [NCS] in Edmonton, Alberta) and Alaska (Arctic Investigations Program [AIP]). The World Health Organization's Collaborating Centre for Reference and Research on Pneumococci at the Statens Serum Institute (SSI) in Copenhagen, Denmark, joined the QC program in 2004. The Iceland Reference Laboratory (IRL) in Reykjavik, Iceland, joined the QC program in 2006, but due to small sample sizes, data from IRL are not included in this report. From 1999 through 2008, 190 isolates were distributed among four laboratories (AIP, NCS, LSPQ, and SSI). The overall serotype concordance was 95.8%, and the overall serogroup concordance was 97.4%. The overall modal MIC concordance for testing by broth microdilution (BMD) and agar dilution was >96% for all the antibiotics except erythromycin (92.1%) and clindamycin (89.5%). MIC comparisons between the Etest and BMD resulted in lower concordance for erythromycin (73.9%), clindamycin (65.5%), and trimethoprim-sulfamethoxazole (80%); however, categorical concordance (susceptible, resistant) remained high at 98.6%, 89.1%, and 90.9%, respectively. Our data demonstrate a high degree of correlation of serotyping and antimicrobial susceptibility testing results between four participating laboratories.
DOI: 10.1128/JCM.01238-10
PubMed: 21048017
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000C68
- to stream PubMed, to step Curation: 000C68
- to stream PubMed, to step Checkpoint: 000C68
- to stream Ncbi, to step Merge: 000D70
- to stream Ncbi, to step Curation: 000D70
- to stream Ncbi, to step Checkpoint: 000D70
- to stream Main, to step Merge: 001648
- to stream Main, to step Curation: 001583
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The International Circumpolar Surveillance interlaboratory quality control program for Streptococcus pneumoniae, 1999 to 2008.</title><author><name sortKey="Reasonover, A" sort="Reasonover, A" uniqKey="Reasonover A" first="A" last="Reasonover">A. Reasonover</name><affiliation wicri:level="2"><nlm:affiliation>Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 4055 Tudor Centre Drive, Anchorage, AK 99508, USA. adr3@cdc.gov</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 4055 Tudor Centre Drive, Anchorage, AK 99508</wicri:regionArea><placeName><region type="state">Alaska</region></placeName></affiliation></author><author><name sortKey="Zulz, T" sort="Zulz, T" uniqKey="Zulz T" first="T" last="Zulz">T. Zulz</name></author><author><name sortKey="Bruce, M G" sort="Bruce, M G" uniqKey="Bruce M" first="M G" last="Bruce">M G Bruce</name></author><author><name sortKey="Bruden, D" sort="Bruden, D" uniqKey="Bruden D" first="D" last="Bruden">D. Bruden</name></author><author><name sortKey="Jette, L" sort="Jette, L" uniqKey="Jette L" first="L" last="Jetté">L. Jetté</name></author><author><name sortKey="Kaltoft, M" sort="Kaltoft, M" uniqKey="Kaltoft M" first="M" last="Kaltoft">M. Kaltoft</name></author><author><name sortKey="Lambertsen, L" sort="Lambertsen, L" uniqKey="Lambertsen L" first="L" last="Lambertsen">L. Lambertsen</name></author><author><name sortKey="Parkinson, A" sort="Parkinson, A" uniqKey="Parkinson A" first="A" last="Parkinson">A. Parkinson</name></author><author><name sortKey="Rudolph, K" sort="Rudolph, K" uniqKey="Rudolph K" first="K" last="Rudolph">K. Rudolph</name></author><author><name sortKey="Lovgren, M" sort="Lovgren, M" uniqKey="Lovgren M" first="M" last="Lovgren">M. Lovgren</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:21048017</idno><idno type="pmid">21048017</idno><idno type="doi">10.1128/JCM.01238-10</idno><idno type="wicri:Area/PubMed/Corpus">000C68</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000C68</idno><idno type="wicri:Area/PubMed/Curation">000C68</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000C68</idno><idno type="wicri:Area/PubMed/Checkpoint">000C68</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000C68</idno><idno type="wicri:Area/Ncbi/Merge">000D70</idno><idno type="wicri:Area/Ncbi/Curation">000D70</idno><idno type="wicri:Area/Ncbi/Checkpoint">000D70</idno><idno type="wicri:Area/Main/Merge">001648</idno><idno type="wicri:Area/Main/Curation">001583</idno><idno type="wicri:Area/Main/Exploration">001583</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The International Circumpolar Surveillance interlaboratory quality control program for Streptococcus pneumoniae, 1999 to 2008.</title><author><name sortKey="Reasonover, A" sort="Reasonover, A" uniqKey="Reasonover A" first="A" last="Reasonover">A. Reasonover</name><affiliation wicri:level="2"><nlm:affiliation>Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 4055 Tudor Centre Drive, Anchorage, AK 99508, USA. adr3@cdc.gov</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 4055 Tudor Centre Drive, Anchorage, AK 99508</wicri:regionArea><placeName><region type="state">Alaska</region></placeName></affiliation></author><author><name sortKey="Zulz, T" sort="Zulz, T" uniqKey="Zulz T" first="T" last="Zulz">T. Zulz</name></author><author><name sortKey="Bruce, M G" sort="Bruce, M G" uniqKey="Bruce M" first="M G" last="Bruce">M G Bruce</name></author><author><name sortKey="Bruden, D" sort="Bruden, D" uniqKey="Bruden D" first="D" last="Bruden">D. Bruden</name></author><author><name sortKey="Jette, L" sort="Jette, L" uniqKey="Jette L" first="L" last="Jetté">L. Jetté</name></author><author><name sortKey="Kaltoft, M" sort="Kaltoft, M" uniqKey="Kaltoft M" first="M" last="Kaltoft">M. Kaltoft</name></author><author><name sortKey="Lambertsen, L" sort="Lambertsen, L" uniqKey="Lambertsen L" first="L" last="Lambertsen">L. Lambertsen</name></author><author><name sortKey="Parkinson, A" sort="Parkinson, A" uniqKey="Parkinson A" first="A" last="Parkinson">A. Parkinson</name></author><author><name sortKey="Rudolph, K" sort="Rudolph, K" uniqKey="Rudolph K" first="K" last="Rudolph">K. Rudolph</name></author><author><name sortKey="Lovgren, M" sort="Lovgren, M" uniqKey="Lovgren M" first="M" last="Lovgren">M. Lovgren</name></author></analytic><series><title level="j">Journal of clinical microbiology</title><idno type="eISSN">1098-660X</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Alaska</term><term>Bacterial Typing Techniques (methods)</term><term>Bacterial Typing Techniques (standards)</term><term>Bacteriological Techniques (standards)</term><term>Canada</term><term>Denmark</term><term>Humans</term><term>Iceland</term><term>International Cooperation</term><term>Microbial Sensitivity Tests (methods)</term><term>Microbial Sensitivity Tests (standards)</term><term>Pneumococcal Infections (diagnosis)</term><term>Pneumococcal Infections (microbiology)</term><term>Quality Control</term><term>Serotyping (methods)</term><term>Serotyping (standards)</term><term>Streptococcus pneumoniae (classification)</term><term>Streptococcus pneumoniae (drug effects)</term><term>Streptococcus pneumoniae (isolation & purification)</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Alaska</term><term>Canada</term><term>Denmark</term><term>Iceland</term></keywords><keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Streptococcus pneumoniae</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Pneumococcal Infections</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Streptococcus pneumoniae</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Streptococcus pneumoniae</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Bacterial Typing Techniques</term><term>Microbial Sensitivity Tests</term><term>Serotyping</term></keywords><keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Pneumococcal Infections</term></keywords><keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Bacterial Typing Techniques</term><term>Bacteriological Techniques</term><term>Microbial Sensitivity Tests</term><term>Serotyping</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>International Cooperation</term><term>Quality Control</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Canada</term><term>Danemark</term><term>Islande</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The International Circumpolar Surveillance (ICS) Program was initiated in 1999 to conduct population-based surveillance for invasive pneumococcal disease in select regions of the Arctic. An interlaboratory quality control (QC) program for pneumococcal serotyping and antibiotic susceptibility testing was incorporated into ICS by reference laboratories in northern Canada (Laboratoire de Santé Publique du Québec [LSPQ] in Sainte-Anne de Bellevue, Québec; National Centre for Streptococcus [NCS] in Edmonton, Alberta) and Alaska (Arctic Investigations Program [AIP]). The World Health Organization's Collaborating Centre for Reference and Research on Pneumococci at the Statens Serum Institute (SSI) in Copenhagen, Denmark, joined the QC program in 2004. The Iceland Reference Laboratory (IRL) in Reykjavik, Iceland, joined the QC program in 2006, but due to small sample sizes, data from IRL are not included in this report. From 1999 through 2008, 190 isolates were distributed among four laboratories (AIP, NCS, LSPQ, and SSI). The overall serotype concordance was 95.8%, and the overall serogroup concordance was 97.4%. The overall modal MIC concordance for testing by broth microdilution (BMD) and agar dilution was >96% for all the antibiotics except erythromycin (92.1%) and clindamycin (89.5%). MIC comparisons between the Etest and BMD resulted in lower concordance for erythromycin (73.9%), clindamycin (65.5%), and trimethoprim-sulfamethoxazole (80%); however, categorical concordance (susceptible, resistant) remained high at 98.6%, 89.1%, and 90.9%, respectively. Our data demonstrate a high degree of correlation of serotyping and antimicrobial susceptibility testing results between four participating laboratories.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Alaska</li></region></list><tree><noCountry><name sortKey="Bruce, M G" sort="Bruce, M G" uniqKey="Bruce M" first="M G" last="Bruce">M G Bruce</name><name sortKey="Bruden, D" sort="Bruden, D" uniqKey="Bruden D" first="D" last="Bruden">D. Bruden</name><name sortKey="Jette, L" sort="Jette, L" uniqKey="Jette L" first="L" last="Jetté">L. Jetté</name><name sortKey="Kaltoft, M" sort="Kaltoft, M" uniqKey="Kaltoft M" first="M" last="Kaltoft">M. Kaltoft</name><name sortKey="Lambertsen, L" sort="Lambertsen, L" uniqKey="Lambertsen L" first="L" last="Lambertsen">L. Lambertsen</name><name sortKey="Lovgren, M" sort="Lovgren, M" uniqKey="Lovgren M" first="M" last="Lovgren">M. Lovgren</name><name sortKey="Parkinson, A" sort="Parkinson, A" uniqKey="Parkinson A" first="A" last="Parkinson">A. Parkinson</name><name sortKey="Rudolph, K" sort="Rudolph, K" uniqKey="Rudolph K" first="K" last="Rudolph">K. Rudolph</name><name sortKey="Zulz, T" sort="Zulz, T" uniqKey="Zulz T" first="T" last="Zulz">T. Zulz</name></noCountry><country name="États-Unis"><region name="Alaska"><name sortKey="Reasonover, A" sort="Reasonover, A" uniqKey="Reasonover A" first="A" last="Reasonover">A. Reasonover</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001583 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001583 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:21048017
|texte= The International Circumpolar Surveillance interlaboratory quality control program for Streptococcus pneumoniae, 1999 to 2008.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:21048017" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |